The role of vaginal Lactobacillus Rhamnosus (Normogin®) in preventing Bacterial Vaginosis in women with history of recurrences, undergoing surgical menopause: A prospective pilot study

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 10, 2013, Pages 1399-1403

  Parma, M ^a   Dindelli, M ^a   Caputo, L ^a   Redaelli, A ^a   Quaranta, L ^a   Candiani, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bacterial vaginosis recurrences; Lactobacillus Rhamnosus; Surgical menopause

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE; NORMOGIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LACTOBACILLUS RHAMNOSUS; MENOPAUSE; RECURRENT DISEASE; VAGINITIS;

FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RECURRENCE; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84878541337     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. SOBEL JD. Vaginitis. New Engl J Med 1997; 337: 1896-1903.
2. SPIEGGEL CA. Bacterial vaginosis. Clin Microbial Rev 1991; 4: 485-502.
3. THOMASON JL, GELBART SM, SCAGLIONE NJ. Bacterial vaginosis: current review indications for asymptomatic therapy. Am J Obstet Gynecol 1991; 165(4 Pt 2): 1210-1217.
4. HART G. Factors associated with trichomoniasis, candidasis and bacterial vaginosis. Int J STD AIDS 1993; 4: 21-25.
5. MIRZA NB, SOUZA MA, D'COSTA LJ, PIOT P. Microbiology of vaginal discharge in Nairobi, Kenya. Br J Vener Dis 1983; 59: 186-188.
6. RAY A, GULATI AK, PANDEY LK, PANDEY S. Prevalence of common infective agents of vaginitis. J Commun Dis 1989; 21: 241-244.
7. MORRIS M, NICOLL A, SIMMS I, WILSON J, CATCHPOLE M. Bacterial vaginosis: a public health review. BJOG 2001; 108: 439-450.
8. TAHA TE, HOOVER DR, DALLABETTA GA, KUMWENDA NI, MTIMAVALYE LAR, YANG LP, LIOMBA GN, BROADHEAD RL, CHIPHANGWI JD, MIOTTI PG. Bacterial vaginosis and disturbance of vaginal flora: associated with increased acquisition of HIV. AIDS 1998; 12: 1699-1706.
9. AMSEL R, TOTTEN PA, SPIEGEL CA, CHEN KC, ESCHENBACH D, HOLMES KK. Nonspecific vaginitis. Diagnostic criteria and microbial epidemiologic associations. Am J Med 1983; 74: 14-22.
10. FORSUM U, HALLEN A, LARSSON PG. Bacterial vaginosis-a laboratory and clinical diagnostics enigma. APMIS 2005; 113: 153-161.
11. NYIRJESY P, MCINTOSH MJ, GATTERMEIR DJ, SCHUMACHER RJ, STEINMETZ JI, JOFFRION JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactopbacilli in patients with bacterial vaginosis. Am J Obstet Gynecol 2006; 194: 1277-1282.
12. HAWES SE, HILLIER SL, BENEDETTI J, STEVENS CE, KOUTSKY LA, WOLNER-HANSSEN P, WOLNER-HANSSEN P, HOLMES KK. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063.
13. MASTROMARINO P, BRIGIDI P, MACCHIA S, MAGGI L, PIROVANO F, TRINCHIERI V, CONTE U, MATTEUZZI D. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 2000; 93: 884-893.
14. MCLEAN NW, MCGROARTY JA. Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by lactobacilli in vitro. Appl Environ Microbiol 1996; 62: 1089-1092.
15. OSSET J, BARTOLOME RM, GRACIA E, ANDREU A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183: 485-491.
16. SHALEV E, BATTINO S, WEINER E, COLODNER R, KENESS Y. Investigation of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996; 5: 593-596.
17. REID G, CHARBONNEAU D, ERB J, KOCHANOWSKI B, BEUERMAN D, POEHNER R, BRUCE AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immun Med Microbiol 2003; 35: 131-134.
18. REID G, MILLSAP K, BRUCE AV. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 1994; 344(8931): 1229.
19. AMESEL R, TROTTEN PA, SPEGEL CA, CHEN KC, ESCHENBACH D, HOLMES KK. Non specific vaginitis. Diagnostic criteria and microbial and repidemiologic associations. Am J Med 1983; 74: 14-22.
20. HALLEN A, JARSTRAND C, PAHLSON C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992; 19: 146-148.
21. OZKINAY E, TEREK MC, YAYCI M, KAISER R, GROB P, TUNCAY G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. Int J Obstet Gynecol 2005; 112: 234-240.
22. MARCONE V, ROCCA G, LICHTNER M, CALZOLARI E. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynaecol Obstet 2010; 110: 223-226.
23. MARCONE V, CALZOLARI E, BERTINI M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008; 31: 429-433.
24. NYIRJESY P. Postmenopausal Vaginitis. Curr Infect Dis Rep 2007; 9: 480-484.
25. HEINEMANN C, REID G. Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol 2005; 51: 777-781.
26. DAHN A, SAUNDERS S, HAMMOND JA, CARTER D, KITJAVAINEN P, ANUKAM K, REID G. Effect of bacterial vaginosis, lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes. Microbes Infect 2008; 10: 620-627.
27. CAUCI S, DRIUSSI S, DE SANTO D, PENACCHIONI P, IANNICELLI T, LANZAFAME P, DE SETA F, QUADRIFOGLIO F, DE ALOYSIO D, GUASCHINO S. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol 2002; 40: 2147-2152.
28. ARMSTRONG NR, WILSON JD. Tinidazole in the treatment of bacterial vaginosis. Int J Womens Health 2010; 1: 59-65.
29. GILLIS JC, WISEMAN LR. Secnidazole: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in themanagement of protozoal infections and bacterial vaginosis. Drugs 1996; 51: 621-638.
30. SENOK AC, VERSTRAELEN H, TEMMERMAN M, BOTTA GA. Probiotics for the treatment of bacterial vaginosis Cochrane Database Syst Rev 2009; (4): CD006289.
31. FALAGAS ME, BETSI GI, ATHANASIOU S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 2007; 13: 657-664.
32. ROSSI A, ROSSI T, BERTINI M, CACCIA G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a populat ion of 40 women treated for 24 months. Arch Gynecol Obstet 2010; 281: 1065-1069.
33. MARELLI G, PAPALEO E, FERRARI A. Lactobacilli for prevention of urogenital infections: a review Eur Rev Med Pharmacol Sci 2004; 8: 87-95.